Last updated on June 2019

Post-Marketing Surveillance Study of Fycompa Film-coated Tablets in Korean Patients


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Epilepsy
  • Age: Between 12 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Participants with approved indication for Fycompa in Korea: the adjunctive therapy for treatment of partial-onset seizures with or without secondarily generalized seizures in participants with epilepsy aged 12 years and older
  • Participants who have written consent for use of personal and medical information for the study purpose

Exclusion Criteria:

  • Hypersensitivity to the active substance or to any of the excipients of this medicine
  • Fycompa contains lactose; therefore, participants with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medicine
  • Other participants judged to be inadequate to participate in the study by doctor

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.